ARCHIVES

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008

DePinho’s Letter to the AAUP

May 30, 2014

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

March 25, 1983

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

FDA Committee to Discuss Policy On Combinations

January 7, 1977